ACCELERATE 2011 |
Follow‐up only 32 weeks |
BENEDICT‐B 2011 |
We requested data of participants naive to antihypertensive drugs. Authors provided individual participant data, but there were fewer than 50 participants per group (trandolapril: 39 participants, trandolapril + verapamil: 40 participants). |
DEMAND 2011 |
We requested data of participants naïve to antihypertensive drugs. Authors provided individual participant data, but there were fewer than 50 participants per group (delapril: 33 participants, delapril + manidipine participants: 38). |
MRC‐O 1992 |
Single‐blind trial. |
ONTARGET 2008 |
Participants entered a run‐in period in which they received ramipril 2.5 mg once daily for 3 days, followed by telmisartan 40 mg + ramipril 2.5 mg once daily for 7 days and then ramipril 5 mg + telmisartan 40 mg for 11 to 18 days; so participants were not naive to antihypertensive treatment at randomization. |
PICXEL 2005 |
We requested data of participants naive to antihypertensive drugs. Authors provided aggregate data, but there were fewer than 50 participants per group (enalapril: 46 participants, perindopril + indapamide: 40 participants). |
Zhang 2010 |
Not stated that it was a double‐blind trial. No data of any of our primary outcomes. |